Showing 1 - 2 results of 2 for search 'James D’Rozario', query time: 0.02s Refine Results
  1. 1
    Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL

    Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL by James D’Rozario, Samuel K. Bennett

    Published 2019-05-01
    Get full text
    Article
  2. 2
    Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)

    Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) by Anna Kalff, Tiffany Khong, Malarmathy Ramachandran, P Joy Ho, Peter Mollee, James D’Rozario, Kerry Taylor, Jane Estell, Sam Norton, Roslyn Kemp, Andrew J. Mitchell, John Reynolds, Nola Kennedy, Hang Quach, Andrew Spencer

    Published 2021-09-01
    Get full text
    Article

Search Tools: